Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jin Medical International (ZJYL) Accounts Payables (2022 - 2025)

Jin Medical International's Accounts Payables history spans 4 years, with the latest figure at $3.3 million for Q3 2025.

  • For Q3 2025, Accounts Payables rose 5900.23% year-over-year to $3.3 million; the TTM value through Sep 2025 reached $3.3 million, up 5900.23%, while the annual FY2025 figure was $3.3 million, 5900.23% up from the prior year.
  • Accounts Payables for Q3 2025 was $3.3 million at Jin Medical International, up from $54275.0 in the prior quarter.
  • Across five years, Accounts Payables topped out at $3.4 million in Q3 2023 and bottomed at $54275.0 in Q3 2024.
  • The 4-year median for Accounts Payables is $1.8 million (2022), against an average of $1.8 million.
  • The largest annual shift saw Accounts Payables tumbled 98.4% in 2024 before it soared 5900.23% in 2025.
  • A 4-year view of Accounts Payables shows it stood at $393760.0 in 2022, then skyrocketed by 761.2% to $3.4 million in 2023, then crashed by 98.4% to $54275.0 in 2024, then skyrocketed by 5900.23% to $3.3 million in 2025.
  • Per Business Quant, the three most recent readings for ZJYL's Accounts Payables are $3.3 million (Q3 2025), $54275.0 (Q3 2024), and $3.4 million (Q3 2023).